During the past 12 months, Agenus's average Revenue per Share Growth Rate was 25.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -3.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 17.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Agenus was 96.00% per year. The lowest was -53.90% per year. And the median was 3.50% per year.
Competitive Comparison of Agenus's 3-Year Revenue Growth Rate
For the Biotechnology subindustry, Agenus's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agenus's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Agenus's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Agenus's 3-Year Revenue Growth Rate falls into.
Agenus 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Agenus 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Agenus's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AGEN has been successfully added to your